Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | CA1 | P00915 | 4/20 | 0.58 |
| ▸ | CA2 | P00918 | 4/20 | 0.58 |
| ▸ | CA7 | P43166 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | PLK1 | P53350 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9622317 | 1.00 | CYP3A4 (0.65) | CYP3A4TSHRCA1CA2CA7 | |
| SCHEMBL28464795 | 0.91 | PKM (0.62) | CYP3A4TSHRCA1CA2CA7 | |
| SCHEMBL22585040 | 0.91 | CYP3A4 (0.83) | CYP3A4TSHRCA1CA2CA7 | |
| Nitrogen SCHEMBL28055470 | 0.86 | CYP3A4 (0.50) | CYP3A4TSHRCA1CA2CA7 | |
| SCHEMBL4277318 | 0.86 | CYP3A4 (0.50) | CYP3A4TSHRCA1CA2CA7 | |
| SCHEMBL9621858 | 0.86 | CYP3A4 (0.50) | CYP3A4TSHRCA1CA2CA7 | |
| SCHEMBL14583060 | 0.84 | CYP3A4 (0.48) | CYP3A4TSHRCA1CA2HTT | |
| SCHEMBL20710745 | 0.83 | CA1 (0.62) | CYP3A4TSHRCA1CA2CA7 | |
| SCHEMBL29153993 | 0.81 | CYP3A4 (0.45) | CYP3A4TSHRCA1CA2CA7 | |
| SCHEMBL3246349 | 0.80 | CES2 (0.53) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114583392-A | Slurry of metal-organic framework material-based heat-resistant flame-retardant film and preparation method and application thereof | 广东工业大学 | 2022-06-03 | — | — | CN | claimed |
| WO-2021064059-A1 | NON-METALLIC PHOSPHORUS ANTIWEAR ADDITIVES | CASTROL LIMITED (GB) | 2021-04-08 | — | — | WO | claimed |
| CN-111987361-A | Imidazole polyion liquid electrolyte and preparation method and application thereof | 仲恺农业工程学院 | 2020-11-24 | — | — | CN | claimed |
| CN-108736013-B | Battery module containing functional coating | 桑德新能源技术开发有限公司 | 2020-03-20 | — | — | CN | claimed |
| EP-4306530-B1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | CHUBU UNIV EDUCATIONAL FOUNDATION (JP) | 2026-04-01 | — | — | EP | disclosed |
| US-20250296954-A1 | METHOD FOR PRODUCING POLYPEPTIDE COMPOUND | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2025-09-25 | — | — | US | disclosed |
| US-12334502-B2 | Electrolytes for lithium-containing battery cells | APPLE INC. (US) | 2025-06-17 | — | — | US | disclosed |
| CN-120040498-A | Tris (4-methoxyphenyl) phosphate, preparation method and application | 盛虹动能科技(泰州)有限公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-120040498-A | Tris (4-methoxyphenyl) phosphate, preparation method and application | 盛虹动能科技(泰州)有限公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-120040498-A | Tris (4-methoxyphenyl) phosphate, preparation method and application | 盛虹动能科技(泰州)有限公司 | 2025-05-27 | — | — | CN | disclosed |
| US-20250092088-A1 | PEPTIDE COMPOUND PRODUCTION METHOD | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2025-03-20 | — | — | US | disclosed |
| EP-4516799-A1 | METHOD FOR PRODUCING POLYPEPTIDE COMPOUND | Chubu University Educational Foundation (JP) | 2025-03-05 | — | — | EP | disclosed |
| EP-1209200-B1 | Polyester composition and connector | TORAY INDUSTRIES (JP) | 2007-03-07 | — | — | EP | disclosed |
| US-20050080200-A1 | Electrical connector | KUMAZAWA SADANORI (JP) | 2005-04-14 | — | — | US | disclosed |
| US-20050003339-A1 | Method of detecting ps2v | SYSMEX CORPORATION (JP) | 2005-01-06 | — | — | US | disclosed |
| US-6838529-B2 | Polyester composition and connector | TORAY INDUSTRIES, INC. (JP) | 2005-01-04 | — | — | US | disclosed |
| US-20040242803-A1 | Resin composition and molded article, film, and fiber each comprising the same | TORAY INDUSTRIES, INC. (JP) | 2004-12-02 | — | — | US | disclosed |
| EP-1445282-A1 | RESIN COMPOSITION AND MOLDED ARTICLE FILM AND FIBER EACH COMPRISING THE SAME | TORAY INDUSTRIES, INC. (JP) | 2004-08-11 | — | — | EP | disclosed |
| US-20020099150-A1 | Polyester composition and connector | TORAY INDUSTRIES, INC. (JP) | 2002-07-25 | — | — | US | disclosed |
| EP-1209200-A2 | Polyester composition and connector | TORAY INDUSTRIES, INC. (JP) | 2002-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250092088-A1 | PEPTIDE COMPOUND PRODUCTION METHOD | VIP, NPPA, HM13 | CYP3A4 2640/4885TSHR 667/4885CA1 569/4885 |
| US-20250296954-A1 | METHOD FOR PRODUCING POLYPEPTIDE COMPOUND | VIP, NPR1, NPPA | CYP3A4 2716/4885TSHR 62/4885CA1 555/4885 |
| US-12334502-B2 | Electrolytes for lithium-containing battery cells | CEL, CA3, SLC9B2 | CYP3A4 2881/4885TSHR 3117/4885CA1 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.